Cite
HARVARD Citation
Phrueksotsai, S. et al. (2021). The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non‐alcoholic fatty liver disease. Journal of gastroenterology and hepatology. 36 (10), pp. 2952-2959. [Online].